Yasushi Nakamura Selected Research

Yasushi Nakamura Research Topics

Disease

50	Neoplasms (Cancer) 01/2019 - 01/2002
19	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2002
16	Carcinoma (Carcinomatosis) 12/2018 - 06/2002
14	Lymphatic Metastasis 04/2014 - 02/2003
11	Neoplasm Metastasis (Metastasis) 12/2018 - 06/2002
8	Carcinogenesis 01/2018 - 11/2002
8	Papillary Thyroid Cancer 01/2017 - 04/2003
7	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2008
6	Adenocarcinoma 03/2013 - 10/2002
6	Lymphoma (Lymphomas) 10/2006 - 01/2003
5	Colonic Neoplasms (Colon Cancer) 08/2020 - 03/2005
5	Body Weight (Weight, Body) 01/2019 - 03/2013
5	Stomach Neoplasms (Stomach Cancer) 02/2013 - 06/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 04/2009
3	Thyroid Neoplasms (Thyroid Cancer) 01/2017 - 06/2005
3	Disease Progression 05/2012 - 06/2009
3	Papillary Carcinoma 10/2006 - 04/2003
2	Colitis 01/2019 - 11/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 07/2011
2	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 08/2014
2	Hepatitis 11/2013 - 07/2013
2	Hyperplasia 03/2013 - 12/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012 - 01/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2005 - 12/2002
2	Medullary Carcinoma 06/2005 - 01/2005
2	Chronic Thyroiditis 03/2004 - 01/2004
2	Ductal Carcinoma 11/2002 - 01/2002

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2002
9	Messenger RNA (mRNA)IBA 11/2013 - 06/2002
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2003
6	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 04/2009
5	4-(methylthio)-3-butenyl isothiocyanateIBA 01/2019 - 03/2013
5	Estrogen ReceptorsIBA 12/2018 - 05/2002
5	Vascular Endothelial Growth Factor CIBA 04/2014 - 04/2003
5	Vascular Endothelial Growth Factor DIBA 11/2011 - 02/2003
4	AcidsIBA 01/2023 - 09/2002
4	EstersIBA 01/2023 - 05/2008
4	AntibodiesIBA 12/2014 - 06/2002
4	NitritesIBA 11/2008 - 02/2006
4	NitratesIBA 11/2008 - 02/2006
4	3-nitrotyrosineIBA 11/2008 - 02/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2008 - 02/2006
3	pyroglutamylleucineIBA 01/2019 - 07/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 12/2018 - 11/2003
3	Gemcitabine FDA Link 01/2017 - 07/2011
3	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 01/2002
3	CEACAM1 ProteinIBA 12/2014 - 08/2011
3	Protein Isoforms (Isoforms)IBA 12/2014 - 08/2011
3	ParaffinIBA 11/2002 - 06/2002
2	3-methylthiopropionateIBA 12/2020 - 05/2008
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2019
2	LigandsIBA 01/2019 - 01/2018
2	Leucine (L-Leucine)FDA Link 01/2019 - 07/2013
2	Peptides (Polypeptides)IBA 01/2019 - 07/2013
2	Thyroglobulin FDA Link 12/2018 - 06/2009
2	CarcinogensIBA 01/2018 - 01/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 12/2002
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2014 - 03/2010
2	Chromogranin AIBA 07/2013 - 01/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2013 - 10/2006
2	Troleandomycin (TAO)FDA Link 01/2013 - 06/2009
2	Chemokine ReceptorsIBA 10/2012 - 05/2010
2	Small Interfering RNA (siRNA)IBA 04/2012 - 08/2011
2	Ethanol (Ethyl Alcohol)IBA 02/2012 - 01/2004
2	Matrix Metalloproteinases (MMPs)IBA 02/2012 - 10/2006
2	Neuropilin-2IBA 11/2011 - 07/2009
2	Hormones (Hormone)IBA 01/2011 - 12/2003
2	ChemokinesIBA 05/2010 - 04/2009
2	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2009 - 11/2008
2	Connexin 43 (Connexin43)IBA 06/2009 - 03/2005
2	VimentinIBA 06/2009 - 06/2002
2	Transcription Factors (Transcription Factor)IBA 05/2006 - 09/2003
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2005 - 03/2004
2	Carrier Proteins (Binding Protein)IBA 06/2005 - 09/2003
2	Antineoplastic Agents (Antineoplastics)IBA 03/2005 - 01/2003
2	Polo-Like Kinase 1IBA 01/2005 - 01/2004
2	EnzymesIBA 12/2003 - 06/2002
2	RetinoidsIBA 04/2003 - 09/2002
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 04/2003 - 02/2003
2	fragile histidine triad proteinIBA 09/2002 - 09/2002
2	Thymidine PhosphorylaseIBA 02/2002 - 01/2002
2	Methotrexate (Mexate)FDA LinkGeneric 02/2002 - 01/2002
2	Tamoxifen FDA LinkGeneric 02/2002 - 01/2002
1	durvalumabIBA 03/2024
1	Pemetrexed (MTA)FDA Link 01/2023
1	OxidesIBA 08/2020
1	piperitenoneIBA 08/2020
1	Volatile Oils (Essential Oils)IBA 08/2020
1	Antimicrobial PeptidesIBA 01/2019

Therapy/Procedure

12	Therapeutics 01/2023 - 01/2002
9	Drug Therapy (Chemotherapy) 01/2023 - 02/2002
3	Adjuvant Chemotherapy 01/2019 - 04/2009
2	Oral Administration 01/2019 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 01/2017 - 07/2011
2	Radiotherapy 04/2012 - 08/2009
2	Pancreatectomy 01/2011 - 01/2008
2	Lasers (Laser) 04/2009 - 01/2004
2	Gastrectomy 01/2008 - 10/2006
1	Chemoradiotherapy 03/2024
1	Immunotherapy 01/2019